TD ASSET MANAGEMENT INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$2,071,000
-17.5%
64,808
-10.6%
0.00%0.0%
Q1 2022$2,510,000
-18.0%
72,474
-30.7%
0.00%
-33.3%
Q4 2021$3,061,000
+71.5%
104,586
+49.3%
0.00%
+50.0%
Q3 2021$1,785,000
-6.8%
70,0740.0%0.00%0.0%
Q2 2021$1,915,000
-44.6%
70,074
-17.4%
0.00%
-50.0%
Q1 2021$3,458,000
-2.4%
84,856
+3.8%
0.00%0.0%
Q4 2020$3,542,000
-23.5%
81,786
-2.6%
0.00%
-33.3%
Q3 2020$4,632,000
-21.7%
84,011
-10.4%
0.01%
-25.0%
Q2 2020$5,917,000
+17.5%
93,728
-4.9%
0.01%
-11.1%
Q1 2020$5,037,000
-41.7%
98,582
-9.2%
0.01%
-30.8%
Q4 2019$8,635,000
+112.5%
108,629
+29.7%
0.01%
+116.7%
Q3 2019$4,063,000
+1.7%
83,729
+10.2%
0.01%0.0%
Q2 2019$3,997,000
+15.3%
75,991
+16.0%
0.01%
+20.0%
Q1 2019$3,467,000
+36.0%
65,495
+5.5%
0.01%
+25.0%
Q4 2018$2,549,000
+9.1%
62,095
+1.0%
0.00%
+33.3%
Q3 2018$2,336,000
+2.0%
61,461
+21.3%
0.00%0.0%
Q2 2018$2,290,000
-1.3%
50,661
+5.4%
0.00%
-25.0%
Q1 2018$2,321,000
+73.1%
48,061
+41.0%
0.00%
+100.0%
Q4 2017$1,341,00034,0750.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders